US 11352428
Modulation of immune response using BTLA agonist antibodies
granted A61KA61K2039/505A61P
Quick answer
US patent 11352428 (Modulation of immune response using BTLA agonist antibodies) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
- Grant date
- Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/505, A61P, A61P29/00, A61P37/00